The effectiveness of SGLT2 inhibitor in the incidence of atrial fibrillation/atrial flutter in patients with type 2 diabetes mellitus/heart failure: a systematic review and meta-analysis

BACKGROUND: Type 2 diabetes mellitus (T2D) and heart failure (HF) are closely related to the increased risk of atrial fibrillation (AF)/atrial flutter (AFL). However, massive clinical studies have shown that sodium glucose cotransporter 2 inhibitor (SGLT2i) affects the occurrence of AF/AFL and its c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Miaomiao, Zhang, Yao, Wang, Zhiyong, Liu, Danliang, Mao, Shaobin, Liang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186250/
https://www.ncbi.nlm.nih.gov/pubmed/35693625
http://dx.doi.org/10.21037/jtd-22-550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186250/
https://www.ncbi.nlm.nih.gov/pubmed/35693625
http://dx.doi.org/10.21037/jtd-22-550

Ejemplares similares